https://pharmadog.xyz/news/267526 pharmadog en 2026-08-17T17:28:00.000Z Drugmakers Back US Probe into Germany’s New Drug Pricing Policies https://pharmadog.xyz/news/267255 pharmadog en 2026-08-17T16:12:00.000Z Argenx reports positive Phase 3 results for Vyvgart Hytrulo in myositis https://pharmadog.xyz/news/266935 pharmadog en 2026-08-17T15:38:40.000Z EyePoint’s Phase 3 eye drug falls short of Eylea, stock tumbles 70% https://pharmadog.xyz/news/267132 pharmadog en 2026-08-17T15:31:00.000Z EyePoint shares tumble as Durayvu misses primary goal in wet AMD trial https://pharmadog.xyz/news/267257 pharmadog en 2026-08-17T15:13:00.000Z AstraZeneca halts Phase 3 lung cancer trial of bispecific antibody volrustomig after interim data miss survival goal https://pharmadog.xyz/news/266936 pharmadog en 2026-08-17T15:12:10.000Z Biotech raises $820M to bring China-sourced immunology drug to market via reverse merger https://pharmadog.xyz/news/266744 pharmadog en 2026-08-17T14:53:46.000Z AstraZeneca reports positive late-stage results for Tagrisso-Orpathys combo and Enhertu in lung cancer https://pharmadog.xyz/news/266745 pharmadog en 2026-08-17T14:48:39.000Z Summit and Akeso's ivonescimab wins Chinese first-line lung cancer approval, but longer follow-up shows reduced benefit https://pharmadog.xyz/news/266788 pharmadog en 2026-08-17T14:40:47.000Z STAT+: The IRS is probing UnitedHealth, and a private equity slowdown https://pharmadog.xyz/news/266768 pharmadog en 2026-08-17T14:40:39.000Z EyePoint’s Phase 3 fail sends stock spiraling amid next-gen AMD race https://pharmadog.xyz/news/266746 pharmadog en 2026-08-17T14:36:05.000Z Lilly to pay up to $370M for OmniAb collab; Slate, Fulcrum forge reverse merger https://pharmadog.xyz/news/134233 pharmadog en 2026-08-17T14:26:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/267258 pharmadog en 2026-08-17T14:23:40.000Z Slate, Fulcrum to combine in reverse merger https://pharmadog.xyz/news/266627 pharmadog en 2026-08-17T14:10:28.000Z Summit Therapeutics and Akeso celebrate third China approval for ivonescimab as new data show waning survival benefit https://pharmadog.xyz/news/266379 pharmadog en 2026-08-17T13:38:15.000Z Akeso and Summit’s lung cancer candidate shows worsening tumor progression, while Europe halts Tavneos over trial concerns https://pharmadog.xyz/news/266380 pharmadog en 2026-08-17T13:22:17.000Z AstraZeneca halts late-stage trial of volrustomig in metastatic lung cancer https://pharmadog.xyz/news/266335 pharmadog en 2026-08-17T13:19:34.000Z Celcuity awaits FDA review for second factory to launch cancer drug https://pharmadog.xyz/news/267501 pharmadog en 2026-08-17T13:06:00.000Z Merck KGaA lays off 20 staffers in latest blow to US research team https://pharmadog.xyz/news/266192 pharmadog en 2026-08-17T12:11:57.000Z AstraZeneca halts late-stage lung cancer trial of volrustomig after disappointing interim results https://pharmadog.xyz/news/266015 pharmadog en 2026-08-17T12:03:57.000Z Trump administration issues executive order overhauling federal vaccine program, drawing WHO criticism https://pharmadog.xyz/news/265995 pharmadog en 2026-08-17T12:02:43.000Z Vera Therapeutics receives FDA accelerated approval for Trutakna, an IgA nephropathy drug showing promising kidney function stabilization https://pharmadog.xyz/news/265867 pharmadog en 2026-08-17T11:39:30.000Z J&J returns rights to lymphoma CAR‑T therapy prizlon‑cel to AbelZeta https://pharmadog.xyz/news/265539 pharmadog en 2026-08-17T10:51:24.000Z Argenx reports Phase 3 success for Vyvgart Hytrulo in autoimmune myositis, despite subgroup shortfall https://pharmadog.xyz/news/265540 pharmadog en 2026-08-17T10:47:39.000Z AstraZeneca halts Phase 3 lung cancer trial of volrustomig after negative results https://pharmadog.xyz/news/266694 pharmadog en 2026-08-17T09:31:00.000Z Slate uses Fulcrum to vault onto Nasdaq with $245M financing for migraine trials https://pharmadog.xyz/news/266577 pharmadog en 2026-08-17T09:20:00.000Z Evaxion scraps solid tumor vaccine to focus on Duke-partnered brain cancer candidate https://pharmadog.xyz/news/265052 pharmadog en 2026-08-17T08:30:00.000Z RFK Jr. contrasts vaccine push in D.C. with addiction-treatment focus in California https://pharmadog.xyz/news/265054 pharmadog en 2026-08-17T08:30:00.000Z Epic faces antitrust lawsuits and internal AI strategy turmoil ahead of annual user meeting https://pharmadog.xyz/news/265055 pharmadog en 2026-08-17T08:30:00.000Z North Carolina’s bipartisan Medicaid pilot shows social services can cut health costs https://pharmadog.xyz/news/265056 pharmadog en 2026-08-17T08:30:00.000Z Paid paternity leave framed as preventive pediatric care in new opinion piece https://pharmadog.xyz/news/265053 pharmadog en 2026-08-17T08:30:00.000Z IRS launches probe into UnitedHealth over alleged tax avoidance from 2017-2020 https://pharmadog.xyz/news/266096 pharmadog en 2026-08-17T07:53:00.000Z FDA clears Lantheus' Tauklarify PET imaging agent for Alzheimer’s tau detection https://pharmadog.xyz/news/266097 pharmadog en 2026-08-17T07:44:00.000Z Eli Lilly signs up to $370M ion-channel collaboration with OmniAb https://pharmadog.xyz/news/264471 pharmadog en 2026-08-17T07:00:00.000Z Italian biotech sector gains traction as venture capital and tech transfer improvements boost startups https://pharmadog.xyz/news/266094 pharmadog en 2026-08-17T06:38:00.000Z Baylor Genetics hit by cybersecurity attack targeting patient, staff information https://pharmadog.xyz/news/263979 pharmadog en 2026-08-17T05:01:00.000Z How AI-enabled Software as Medical Devices are Reshaping Regulatory Routes and Medicine https://pharmadog.xyz/news/263743 pharmadog en 2026-08-17T04:01:00.000Z State Laws Cut Private-Equity Acquisitions of Physician Practice Management Firms in Half https://pharmadog.xyz/news/264914 pharmadog en 2026-08-17T04:01:00.000Z AstraZeneca halts phase 3 lung cancer trial of bispecific antibody volrustomig after it falls short of Keytruda